TD Cowen raised its price target for Edwards Lifesciences to $121 and gave it a sell rating.

Nov 11, 2026, 6:37 AM ETOpinionRead the original at marketscreener.com

Neutral

TD Cowen raised its price target but also gave EW a sell rating. The two views conflict, and the story reports no new change to Edwards Lifesciences' business.

EW · Edwards Lifesciences

AI read · Neutral

The AI's read

A price target and a share rating are one firm's opinion, not a report of new sales, product changes, or profit. The higher target and sell rating point in different directions, so this update alone does not change Edwards Lifesciences' outlook.

Get alerts for EW

Follow Edwards Lifesciences (EW) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for EW

Free on the App Store and Google Play, or on the web.